265 related articles for article (PubMed ID: 31672993)
1. Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development.
Beites T; O'Brien K; Tiwari D; Engelhart CA; Walters S; Andrews J; Yang HJ; Sutphen ML; Weiner DM; Dayao EK; Zimmerman M; Prideaux B; Desai PV; Masquelin T; Via LE; Dartois V; Boshoff HI; Barry CE; Ehrt S; Schnappinger D
Nat Commun; 2019 Oct; 10(1):4970. PubMed ID: 31672993
[TBL] [Abstract][Full Text] [Related]
2. Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc
Kalia NP; Shi Lee B; Ab Rahman NB; Moraski GC; Miller MJ; Pethe K
Sci Rep; 2019 Jun; 9(1):8608. PubMed ID: 31197236
[TBL] [Abstract][Full Text] [Related]
3. Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis.
Arora K; Ochoa-Montaño B; Tsang PS; Blundell TL; Dawes SS; Mizrahi V; Bayliss T; Mackenzie CJ; Cleghorn LA; Ray PC; Wyatt PG; Uh E; Lee J; Barry CE; Boshoff HI
Antimicrob Agents Chemother; 2014 Nov; 58(11):6962-5. PubMed ID: 25155596
[TBL] [Abstract][Full Text] [Related]
4. Exploiting the synthetic lethality between terminal respiratory oxidases to kill
Kalia NP; Hasenoehrl EJ; Ab Rahman NB; Koh VH; Ang MLT; Sajorda DR; Hards K; Grüber G; Alonso S; Cook GM; Berney M; Pethe K
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7426-7431. PubMed ID: 28652330
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Mycobacterium ulcerans cytochrome bc
Scherr N; Bieri R; Thomas SS; Chauffour A; Kalia NP; Schneide P; Ruf MT; Lamelas A; Manimekalai MSS; Grüber G; Ishii N; Suzuki K; Tanner M; Moraski GC; Miller MJ; Witschel M; Jarlier V; Pluschke G; Pethe K
Nat Commun; 2018 Dec; 9(1):5370. PubMed ID: 30560872
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome bc1-aa3 Oxidase Supercomplex As Emerging and Potential Drug Target Against Tuberculosis.
Sindhu T; Debnath P
Curr Mol Pharmacol; 2022; 15(2):380-392. PubMed ID: 34602044
[TBL] [Abstract][Full Text] [Related]
7. Plasticity of
Vilchèze C; Weinrick B; Leung LW; Jacobs WR
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1599-1604. PubMed ID: 29382761
[TBL] [Abstract][Full Text] [Related]
8. Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.
Sellamuthu S; Singh M; Kumar A; Singh SK
Expert Opin Ther Targets; 2017 Jun; 21(6):559-570. PubMed ID: 28472892
[TBL] [Abstract][Full Text] [Related]
9. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
[TBL] [Abstract][Full Text] [Related]
10. Isolation and Characterization of a Hybrid Respiratory Supercomplex Consisting of Mycobacterium tuberculosis Cytochrome bcc and Mycobacterium smegmatis Cytochrome aa3.
Kim MS; Jang J; Ab Rahman NB; Pethe K; Berry EA; Huang LS
J Biol Chem; 2015 Jun; 290(23):14350-60. PubMed ID: 25861988
[TBL] [Abstract][Full Text] [Related]
11. Turning the respiratory flexibility of Mycobacterium tuberculosis against itself.
Lamprecht DA; Finin PM; Rahman MA; Cumming BM; Russell SL; Jonnala SR; Adamson JH; Steyn AJ
Nat Commun; 2016 Aug; 7():12393. PubMed ID: 27506290
[TBL] [Abstract][Full Text] [Related]
12. The cytochrome c reductase/oxidase respiratory pathway of Paracoccus denitrificans: genetic and functional studies.
Steinrücke P; Gerhus E; Jetzek M; Turba A; Ludwig B
J Bioenerg Biomembr; 1991 Apr; 23(2):227-39. PubMed ID: 1646794
[TBL] [Abstract][Full Text] [Related]
13. Targeting the cytochrome oxidases for drug development in mycobacteria.
Lee BS; Sviriaeva E; Pethe K
Prog Biophys Mol Biol; 2020 May; 152():45-54. PubMed ID: 32081616
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis.
Pethe K; Bifani P; Jang J; Kang S; Park S; Ahn S; Jiricek J; Jung J; Jeon HK; Cechetto J; Christophe T; Lee H; Kempf M; Jackson M; Lenaerts AJ; Pham H; Jones V; Seo MJ; Kim YM; Seo M; Seo JJ; Park D; Ko Y; Choi I; Kim R; Kim SY; Lim S; Yim SA; Nam J; Kang H; Kwon H; Oh CT; Cho Y; Jang Y; Kim J; Chua A; Tan BH; Nanjundappa MB; Rao SP; Barnes WS; Wintjens R; Walker JR; Alonso S; Lee S; Kim J; Oh S; Oh T; Nehrbass U; Han SJ; No Z; Lee J; Brodin P; Cho SN; Nam K; Kim J
Nat Med; 2013 Sep; 19(9):1157-60. PubMed ID: 23913123
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Mycobacterium tuberculosis Cytochrome
Moosa A; Lamprecht DA; Arora K; Barry CE; Boshoff HIM; Ioerger TR; Steyn AJC; Mizrahi V; Warner DF
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760899
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid Bactericidal Activity Involves Electron Transport Chain Perturbation.
Zeng S; Soetaert K; Ravon F; Vandeput M; Bald D; Kauffmann JM; Mathys V; Wattiez R; Fontaine V
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642937
[TBL] [Abstract][Full Text] [Related]
17. The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd.
Lu P; Asseri AH; Kremer M; Maaskant J; Ummels R; Lill H; Bald D
Sci Rep; 2018 Feb; 8(1):2625. PubMed ID: 29422632
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Two Novel Inhibitors of the Mycobacterium tuberculosis Cytochrome
Gries R; Dal Molin M; Chhen J; van Gumpel E; Dreyer V; Niemann S; Rybniker J
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0025123. PubMed ID: 37358461
[TBL] [Abstract][Full Text] [Related]
19. Perturbation of cytochrome c maturation reveals adaptability of the respiratory chain in Mycobacterium tuberculosis.
Small JL; Park SW; Kana BD; Ioerger TR; Sacchettini JC; Ehrt S
mBio; 2013 Sep; 4(5):e00475-13. PubMed ID: 24045640
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
Lee AS; Teo AS; Wong SY
Antimicrob Agents Chemother; 2001 Jul; 45(7):2157-9. PubMed ID: 11408244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
